Amanote Research
Register
Sign In
FDA Urges "Black Box" Warning on Pediatric Antidepressants
CMAJ
- Canada
doi 10.1503/cmaj.1041507
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
October 12, 2004
Authors
W. Kondro
Publisher
Joule Inc.
Related search
Impact of FDA Black Box Warning on Fluoroquinolone and Alternative Antibiotic Use in Southeastern US Hospitals
Infection Control and Hospital Epidemiology
Epidemiology
Infectious Diseases
Microbiology
The Suicide Epidemic in Youth and the FDA Black-Box Warning: Time to Reconsider
Psychiatric Annals
Psychiatry
Mental Health
Challenging the FDA Black Box Warning for High Aspirin Dose With Ticagrelor in Patients With Diabetes
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
The FDA Warning on Anesthesia Drugs
Anesthesia Progress
Anesthesiology
Pain Medicine
Performance Improvement CME in Psychiatry: Implementing Black Box Warning Informed Consent
Journal of European CME
The FDA Black Box Warning Does Reduce the Use of Erythropoietin Stimulating Agents and Increases Blood Transfusions in Insured, Low Income Cancer Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Black-Box Non-Black-Box Zero Knowledge
FDA to Review Risks of Antidepressants in Adults
BMJ
FDA Warning to Manufacturers of AIDS Drugs
Western Journal of Medicine
